Previous close | 19.20 |
Open | 19.70 |
Bid | 19.80 x 0 |
Ask | 20.40 x 0 |
Day's range | 19.70 - 19.70 |
52-week range | 18.60 - 37.50 |
Volume | |
Avg. volume | 3 |
Market cap | 599.623M |
Beta (5Y monthly) | 1.42 |
PE ratio (TTM) | N/A |
EPS (TTM) | -5.25 |
Earnings date | 02 Aug 2024 - 06 Aug 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 141.00 |
Despite a slight revenue dip, Fulgent Genetics showcases strategic advancements and robust future prospects in precision diagnostics and pharmaceutical development.
Q1 2024 Fulgent Genetics Inc Earnings Call
Despite Revenue Near Estimates, Losses Exceed Expectations